Literature DB >> 24941337

S-Glutathionylation at Cys328 and Cys542 impairs STAT3 phosphorylation.

Elena Butturini1, Elena Darra, Giulia Chiavegato, Barbara Cellini, Flora Cozzolino, Maria Monti, Piero Pucci, Daniele Dell'Orco, Sofia Mariotto.   

Abstract

STAT3 is a latent transcription factor that promotes cell survival and proliferation and is often constitutively active in cancers. Although many reports provide evidence that STAT3 is a direct target of oxidative stress, its redox regulation is poorly understood. Under oxidative conditions STAT3 activity can be modulated by S-glutathionylation, a reversible redox modification of cysteine residues. This suggests the possible cross-talk between phosphorylation and glutathionylation and points out that STAT3 is susceptible to redox regulation. Recently, we reported that decreasing the GSH content in different cell lines induces inhibition of STAT3 activity through the reversible oxidation of thiol groups. In the present work, we demonstrate that GSH/diamide treatment induces S-glutathionylation of STAT3 in the recombinant purified form. This effect was completely reversed by treatment with the reducing agent dithiothreitol, indicating that S-glutathionylation of STAT3 was related to formation of protein-mixed disulfides. Moreover, addition of the bulky negatively charged GSH moiety impairs JAK2-mediated STAT3 phosphorylation, very likely interfering with tyrosine accessibility and thus affecting protein structure and function. Mass mapping analysis identifies two glutathionylated cysteine residues, Cys328 and Cys542, within the DNA-binding domain and the linker domain, respectively. Site direct mutagenesis and in vitro kinase assay confirm the importance of both cysteine residues in the complex redox regulatory mechanism of STAT3. Cells expressing mutant were resistant in this regard. The data presented herein confirmed the occurrence of a redox-dependent regulation of STAT3, identified the more redox-sensitive cysteines within STAT3 structure, and may have important implications for development of new drugs.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24941337     DOI: 10.1021/cb500407d

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  30 in total

Review 1.  Redox regulation of vascular remodeling.

Authors:  Keyvan Karimi Galougahi; Euan A Ashley; Ziad A Ali
Journal:  Cell Mol Life Sci       Date:  2015-10-20       Impact factor: 9.261

2.  Redox-sensitive residue in the actin-binding interface of myosin.

Authors:  Rebecca J Moen; Sinziana Cornea; Daniel E Oseid; Benjamin P Binder; Jennifer C Klein; David D Thomas
Journal:  Biochem Biophys Res Commun       Date:  2014-09-26       Impact factor: 3.575

Review 3.  Regulation of signal transduction by reactive oxygen species in the cardiovascular system.

Authors:  David I Brown; Kathy K Griendling
Journal:  Circ Res       Date:  2015-01-30       Impact factor: 17.367

4.  Regulation of DJ-1 by Glutaredoxin 1 in Vivo: Implications for Parkinson's Disease.

Authors:  William M Johnson; Marcin Golczak; Kyonghwan Choe; Pierce L Curran; Olga Gorelenkova Miller; Chen Yao; Wenzhang Wang; Jiusheng Lin; Nicole M Milkovic; Ajit Ray; Vijayalakshmi Ravindranath; Xiongwei Zhu; Mark A Wilson; Amy L Wilson-Delfosse; Shu G Chen; John J Mieyal
Journal:  Biochemistry       Date:  2016-08-01       Impact factor: 3.162

5.  Dysregulation of the glutaredoxin/S-glutathionylation redox axis in lung diseases.

Authors:  Shi B Chia; Evan A Elko; Reem Aboushousha; Allison M Manuel; Cheryl van de Wetering; Joseph E Druso; Jos van der Velden; David J Seward; Vikas Anathy; Charles G Irvin; Ying-Wai Lam; Albert van der Vliet; Yvonne M W Janssen-Heininger
Journal:  Am J Physiol Cell Physiol       Date:  2019-11-06       Impact factor: 4.249

6.  A thiazole-derived oridonin analogue exhibits antitumor activity by directly and allosterically inhibiting STAT3.

Authors:  Xiaofei Shen; Lin Zhao; Peihao Chen; Yanqiu Gong; Dingdong Liu; Xia Zhang; Lunzhi Dai; Qingxiang Sun; Jizhong Lou; Zhong Jin; Baohua Zhang; Dawen Niu; Ceshi Chen; Xiangbing Qi; Da Jia
Journal:  J Biol Chem       Date:  2019-10-08       Impact factor: 5.157

Review 7.  Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 to Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution.

Authors:  Uddalak Bharadwaj; Moses M Kasembeli; Prema Robinson; David J Tweardy
Journal:  Pharmacol Rev       Date:  2020-04       Impact factor: 25.468

8.  Hemistepsin a Induces Apoptosis of Hepatocellular Carcinoma Cells by Downregulating STAT3.

Authors:  Il Je Cho; Jae Kwang Kim; Eun Ok Kim; Sang Mi Park; Sang Chan Kim; Sung Hwan Ki; Sae Kwang Ku
Journal:  Int J Mol Sci       Date:  2021-04-29       Impact factor: 5.923

9.  Deletion of Glutathione S-Transferase Omega 1 Activates Type I Interferon Genes and Downregulates Tissue Factor.

Authors:  Yibin Xu; Armand Bankhead; Xiaoli Tian; Jianming Tang; Mats Ljungman; Nouri Neamati
Journal:  Cancer Res       Date:  2020-06-22       Impact factor: 13.312

Review 10.  Pivotal Importance of STAT3 in Protecting the Heart from Acute and Chronic Stress: New Advancement and Unresolved Issues.

Authors:  Fouad A Zouein; Raffaele Altara; Qun Chen; Edward J Lesnefsky; Mazen Kurdi; George W Booz
Journal:  Front Cardiovasc Med       Date:  2015-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.